Cristina Quintana García , Carlos A. Benavides Velasco , Vanesa F. Guzmán Parra
{"title":"研究能力和指令:科技型公司上市的信息信号","authors":"Cristina Quintana García , Carlos A. Benavides Velasco , Vanesa F. Guzmán Parra","doi":"10.1016/j.cede.2013.06.005","DOIUrl":null,"url":null,"abstract":"<div><p>This study is aimed at exploring the effect of research and managerial capabilities of technology-based firms on the capital guaranteed from their initial public offerings. Based on the dynamic capabilities perspective, we formulate a set of hypotheses that suggest that patent value, technological diversity and functional diversity of top management teams are information signals to potential investors and positively influence the valuation of firms going public. A longitudinal empirical research of a sample of dedicated biotechnology firms that went public in the United States provides support for such arguments.</p></div>","PeriodicalId":100345,"journal":{"name":"Cuadernos de Economía y Dirección de la Empresa","volume":"16 4","pages":"Pages 270-280"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cede.2013.06.005","citationCount":"7","resultStr":"{\"title\":\"Capacidades de investigación y directivas: señales informativas en la salida a bolsa de las empresas de base tecnológica\",\"authors\":\"Cristina Quintana García , Carlos A. Benavides Velasco , Vanesa F. Guzmán Parra\",\"doi\":\"10.1016/j.cede.2013.06.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This study is aimed at exploring the effect of research and managerial capabilities of technology-based firms on the capital guaranteed from their initial public offerings. Based on the dynamic capabilities perspective, we formulate a set of hypotheses that suggest that patent value, technological diversity and functional diversity of top management teams are information signals to potential investors and positively influence the valuation of firms going public. A longitudinal empirical research of a sample of dedicated biotechnology firms that went public in the United States provides support for such arguments.</p></div>\",\"PeriodicalId\":100345,\"journal\":{\"name\":\"Cuadernos de Economía y Dirección de la Empresa\",\"volume\":\"16 4\",\"pages\":\"Pages 270-280\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.cede.2013.06.005\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cuadernos de Economía y Dirección de la Empresa\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1138575813000571\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cuadernos de Economía y Dirección de la Empresa","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1138575813000571","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Capacidades de investigación y directivas: señales informativas en la salida a bolsa de las empresas de base tecnológica
This study is aimed at exploring the effect of research and managerial capabilities of technology-based firms on the capital guaranteed from their initial public offerings. Based on the dynamic capabilities perspective, we formulate a set of hypotheses that suggest that patent value, technological diversity and functional diversity of top management teams are information signals to potential investors and positively influence the valuation of firms going public. A longitudinal empirical research of a sample of dedicated biotechnology firms that went public in the United States provides support for such arguments.